Abstract:Background: Current anti-obesity medications suffer from limited efficacy and side-effects because they act indirectly on either the central nervous system or gastrointestinal system. Herein, this work aims to introduce a transdermal photothermal and nanocatalytic therapy enabled by Prussian blue nanoparticles, which directly act on obese subcutaneous white adipose tissue (sWAT) to induce its beneficial remodeling including stimulation of browning, lipolysis, secretion of adiponectin, as well as reduction of oxidative stress, hypoxia, and inflammation. Methods: Prussian blue nanoparticles were synthesized and incorporated into silk fibroin hydrogel for sustained retention. The efficacy of mild photothermal (808 nm, 0.4 W/cm2, 5 min) and nanocatalytic therapy (mPTT-NCT) was assessed both in vitro (3T3-L1 adipocytes) and in vivo (obese mice). The underlying signaling pathways are carefully revealed. Additionally, biosafety studies were conducted to further validate the potential of this therapy for practical application. Results: On 3T3-L1 adipocytes, mPTT-NCT was able to induce browning, enhance lipolysis, and alleviate oxidative stress. On obese mice model, the synergistic treatment led to not only large mass reduction of the targeted sWAT (53.95%) but also significant improvement of whole-body metabolism as evidenced by the substantial decrease of visceral fat (65.37%), body weight (9.78%), hyperlipidemia, and systemic inflammation, as well as total relief of type 2 diabetes. Conclusions: By directly targeting obese sWAT to induce its beneficial remodeling, this synergistic therapy leads to significant improvements in whole-body metabolism and the alleviation of obesity-related conditions, including type 2 diabetes. The elucidation of underlying signaling pathways provides fundamental insights and shall inspire new strategies to combat obesity and its associated diseases.

Adipocyte‐Targeted Nanotechnology and Cell‐Based Therapy for Obesity Treatment

Nanotechnology advances towards development of targeted-treatment for obesity

Nanomedicine for obesity treatment

Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities

Gene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications

Mild-photothermal and nanocatalytic therapy for obesity and associated diseases

Adipocyte-Targeted Nanocomplex with Synergistic Photothermal and Pharmacological Effects for Combating Obesity and Related Metabolic Syndromes

The Potential to Fight Obesity with Adipogenesis Modulating Compounds

Targeting adipose tissue in the treatment of obesity-associated diabetes

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities

Adipocyte-targeted celastrol delivery via biguanide-modified micelles improves treatment of obesity in DIO mice

Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery

Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?

Targeting Nanotechnology and Nutraceuticals in Obesity: An Updated Approach

Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems

Enhancing adipose tissue functionality in obesity: senotherapeutics, autophagy and cellular senescence as a target

Nanomodulator-Mediated Restructuring of Adipose Tissue Immune Microenvironments for Antiobesity Treatment

Gold Nanobipyramid‐Mediated Apoptotic Camouflage of Adipocytes for Obesity Immunotherapy

New advances of adiponectin in regulating obesity and related metabolic syndromes

A nanoemulsion targeting adipose hypertrophy and hyperplasia shows anti-obesity efficiency in female mice

Unleashing the potential of adipose organoids: A revolutionary approach to combat obesity-related metabolic diseases